EGFR and non-small cell lung carcinoma: Therefore, this study aims to systematically evaluate the clinical efficacy and safety of CHM granules combined with chemotherapy for the treatment of stage IIIB/IV NSCLC patients who have developed resistance to EGFR-TKIs.